Eden Research plc
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more
Eden Research plc (EDNSF) - Net Assets
Latest net assets as of June 2025: $10.61 Million USD
Based on the latest financial reports, Eden Research plc (EDNSF) has net assets worth $10.61 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.46 Million) and total liabilities ($2.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.61 Million |
| % of Total Assets | 78.81% |
| Annual Growth Rate | 1.39% |
| 5-Year Change | -20.71% |
| 10-Year Change | 99.73% |
| Growth Volatility | 38.3 |
Eden Research plc - Net Assets Trend (2004–2024)
This chart illustrates how Eden Research plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Eden Research plc (2004–2024)
The table below shows the annual net assets of Eden Research plc from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $11.84 Million | -12.61% |
| 2023-12-31 | $13.55 Million | +26.09% |
| 2022-12-31 | $10.74 Million | -16.26% |
| 2021-12-31 | $12.83 Million | -14.06% |
| 2020-12-31 | $14.93 Million | +103.18% |
| 2019-12-31 | $7.35 Million | -11.23% |
| 2018-12-31 | $8.28 Million | -2.78% |
| 2017-12-31 | $8.51 Million | +25.89% |
| 2016-12-31 | $6.76 Million | +14.11% |
| 2015-12-31 | $5.93 Million | -0.27% |
| 2014-12-31 | $5.94 Million | +4.64% |
| 2013-12-31 | $5.68 Million | +3.12% |
| 2012-12-31 | $5.51 Million | +2.27% |
| 2011-12-31 | $5.39 Million | +106.92% |
| 2010-12-31 | $2.60 Million | -45.27% |
| 2009-12-31 | $4.76 Million | -9.47% |
| 2008-12-31 | $5.25 Million | -14.72% |
| 2007-12-31 | $6.16 Million | +41.28% |
| 2006-12-31 | $4.36 Million | -31.85% |
| 2005-12-31 | $6.40 Million | -28.72% |
| 2004-12-31 | $8.98 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eden Research plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 36662400.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $5.33 Million | 45.13% |
| Other Components | $7.20 Million | 60.96% |
| Total Equity | $11.82 Million | 100.00% |
Eden Research plc Competitors by Market Cap
The table below lists competitors of Eden Research plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Icape Holding
PA:ALICA
|
$12.55 Million |
|
LianBio
PINK:LIANY
|
$12.55 Million |
|
Cellectar Biosciences Inc
NASDAQ:CLRB
|
$12.55 Million |
|
Radhika Jeweltech Limited
NSE:RADHIKAJWE
|
$12.55 Million |
|
Goa Carbon Limited
NSE:GOACARBON
|
$12.54 Million |
|
OCR Group Bhd
KLSE:7071
|
$12.53 Million |
|
Borneo Oil Bhd
KLSE:7036
|
$12.53 Million |
|
Myriad Uranium Corp.
OTCGREY:MYRUF
|
$12.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eden Research plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 13,518,982 to 11,817,319, a change of -1,701,663 (-12.6%).
- Net loss of 1,906,591 reduced equity.
- Other comprehensive income decreased equity by 758,233.
- Other factors increased equity by 963,161.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.91 Million | -16.13% |
| Other Comprehensive Income | $-758.23K | -6.42% |
| Other Changes | $963.16K | +8.15% |
| Total Change | $- | -12.59% |
Book Value vs Market Value Analysis
This analysis compares Eden Research plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.17x to 1.58x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $0.20 | $0.04 | x |
| 2005-12-31 | $0.14 | $0.04 | x |
| 2006-12-31 | $0.10 | $0.04 | x |
| 2007-12-31 | $0.13 | $0.04 | x |
| 2008-12-31 | $0.10 | $0.04 | x |
| 2009-12-31 | $0.04 | $0.04 | x |
| 2010-12-31 | $0.02 | $0.04 | x |
| 2011-12-31 | $0.06 | $0.04 | x |
| 2012-12-31 | $0.05 | $0.04 | x |
| 2013-12-31 | $0.05 | $0.04 | x |
| 2014-12-31 | $0.05 | $0.04 | x |
| 2015-12-31 | $0.04 | $0.04 | x |
| 2016-12-31 | $0.04 | $0.04 | x |
| 2017-12-31 | $0.04 | $0.04 | x |
| 2018-12-31 | $0.04 | $0.04 | x |
| 2019-12-31 | $0.04 | $0.04 | x |
| 2020-12-31 | $0.04 | $0.04 | x |
| 2021-12-31 | $0.03 | $0.04 | x |
| 2022-12-31 | $0.03 | $0.04 | x |
| 2023-12-31 | $0.03 | $0.04 | x |
| 2024-12-31 | $0.02 | $0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eden Research plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -16.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -44.31%
- • Asset Turnover: 0.28x
- • Equity Multiplier: 1.30x
- Recent ROE (-16.13%) is above the historical average (-37.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -25.57% | -6656.04% | 0.00x | 1.13x | $-3.19 Million |
| 2005 | -40.29% | 0.00% | 0.00x | 1.35x | $-3.22 Million |
| 2006 | -93.85% | -3990.22% | 0.01x | 1.74x | $-4.53 Million |
| 2007 | -40.00% | -682.91% | 0.04x | 1.45x | $-3.08 Million |
| 2008 | -40.00% | -2501.38% | 0.01x | 1.63x | $-2.63 Million |
| 2009 | -36.31% | -894.82% | 0.02x | 1.87x | $-2.20 Million |
| 2010 | -124.89% | -1890.12% | 0.02x | 3.18x | $-3.51 Million |
| 2011 | -60.97% | -3608.79% | 0.01x | 1.54x | $-3.82 Million |
| 2012 | -42.07% | -5315.75% | 0.01x | 1.38x | $-2.87 Million |
| 2013 | -27.96% | -1979.37% | 0.01x | 1.15x | $-2.16 Million |
| 2014 | -49.97% | -2973.78% | 0.02x | 1.08x | $-3.56 Million |
| 2015 | -19.52% | -131.00% | 0.13x | 1.13x | $-1.75 Million |
| 2016 | -27.07% | -467.17% | 0.05x | 1.15x | $-2.51 Million |
| 2017 | -7.51% | -34.05% | 0.18x | 1.24x | $-1.49 Million |
| 2018 | -4.05% | -12.07% | 0.30x | 1.11x | $-1.16 Million |
| 2019 | -15.61% | -62.71% | 0.21x | 1.21x | $-1.88 Million |
| 2020 | -15.23% | -165.84% | 0.08x | 1.14x | $-3.76 Million |
| 2021 | -21.79% | -227.01% | 0.08x | 1.17x | $-4.07 Million |
| 2022 | -20.87% | -122.44% | 0.14x | 1.20x | $-3.31 Million |
| 2023 | -48.04% | -203.45% | 0.19x | 1.23x | $-7.85 Million |
| 2024 | -16.13% | -44.31% | 0.28x | 1.30x | $-3.09 Million |
Industry Comparison
This section compares Eden Research plc's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $1,234,454,915
- Average return on equity (ROE) among peers: -88.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eden Research plc (EDNSF) | $10.61 Million | -25.57% | 0.27x | $12.54 Million |
| Argo Living Soils Corp (ARLSF) | $117.11K | -241.15% | 0.57x | $4.77 Million |
| American Vanguard Corporation (AVD) | $282.36 Million | 4.53% | 0.52x | $93.02 Million |
| Bee Vectoring Technologies International Inc (BEVVF) | $1.82 Million | -170.52% | 0.16x | $47.51K |
| Benson Hill, Inc. Common Stock (BHIL) | $86.04 Million | -134.02% | 2.19x | $178.85K |
| BHILW (BHILW) | $86.04 Million | -134.02% | 2.19x | $286.16K |
| Bioceres Crop Solutions Corp (BIOX) | $351.38 Million | 0.92% | 1.43x | $16.37 Million |
| CO2 Gro Inc (BLONF) | $577.93K | -224.34% | 1.65x | $154.65K |
| China BlueChemical Ltd (CBLUF) | $7.05 Billion | 23.77% | 0.29x | $484.41 Million |
| CF Industries Holdings Inc (CF) | $4.39 Billion | 15.96% | 1.90x | $15.33 Billion |
| China Green Agriculture Inc (CGA) | $100.10 Million | -28.38% | 0.63x | $14.93 Million |